Wednesday, June 10, 2026

pharma · Gastric Adenocarcinoma

Basilea Pharmaceutica

Basilea Pharmaceutica patent portfolio — 25 USPTO pharmaceutical patents (A61K/A61P) with grant dates, status, and loss-of-exclusivity filters.

Allschwil, CH HQ
2000 Founded
246 Employees
NMPA registrant Type
Company details
Status
Public
HQ
Allschwil, CH
Founded
2000
Employees
246
Programs
2
Drugs
3
Patents
25
Intelligence · Patents

Basilea Pharmaceutica patents

25 pharmaceutical patents indexed for Basilea Pharmaceutica. 0 expire within 24 months.

Basilea Pharmaceutica has 25 pharmaceutical patents in our USPTO PatentsView index (A61K/A61P). 0 expire within 24 months — use filters for patent-cliff planning.

Patent portfolio

  1. AU 2024384453

    CITRATE COORDINATION COMPLEX OF AN ORALLY-DELIVERED BETA-LACTAMASE INHIBITOR AND USES THEREOF

    Expires Wed May 16 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  2. PT 3886798

    COMBINATION COMPOSITIONS COMPRISING A BETA-LACTAMASE INHIBITOR AND USES THEREOF

    Expires Wed Apr 11 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  3. US 20260042800

    ANTIMICROBIAL PEPTIDOMIMETICS

    Expires Wed Feb 07 2046 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  4. WO 2025114603

    COMBINAISONS PHARMACEUTIQUES DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT D'INFECTIONS FONGIQUES

    Expires Wed May 31 2045 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  5. WO 2024094329

    PRÉPARATION DE CAPSULE SOUS EMBALLAGE COQUE CONTENANT DU SULFATE D'ISAVUCONAZONIUM

    Expires Thu May 05 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  6. CA 3268414

    MÉTHODES DE TRAITEMENT D'INFECTIONS AVEC BACTÉRIÉMIE À STAPHYLOCOCCUS AUREUS

    Expires Wed Apr 13 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  7. AU 2022323463

    ANTIMICROBIAL PEPTIDOMIMETICS

    Expires Wed Feb 24 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  8. AR 127448

    DERIVADOS DE BENZO[H]QUINAZOLIN-4-AMINA PARA EL TRATAMIENTO DEL CÁNCER

    Expires Tue Jan 19 2044 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  9. WO 2023054310

    ENSEMBLE DE PERFUSION GOUTTE-À-GOUTTE INTRAVEINEUX POURVU D'UN FILTRE DE PERFUSION À ÉVENT D'AIR

    Expires Wed Apr 01 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  10. AU 2021319613

    Antimicrobial peptidomimetics

    Expires Wed Mar 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  11. AU 2021323364

    Antimicrobial peptidomimetics

    Expires Wed Mar 25 2043 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  12. AR 123726

    DERIVADOS DE BENZO[H]QUINAZOLIN-4-AMINA Y TIENO[3,2-H]QUINAZOLIN-4-AMINA PARA EL TRATAMIENTO DEL CÁNCER

    Expires Tue Dec 30 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  13. AU 2021230529

    Use of compounds in the treatment of fungal infections

    Expires Wed Sep 24 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  14. TW 202214258

    Compounds and methods for treating fungal infections

    Expires Fri Apr 11 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  15. WO 2022074143

    DÉRIVÉS DE BENZO[H]QUINAZOLIN-4-AMINE ET DE THIÉNO[3,2-H]QUINAZOLIN-4-AMINE POUR LE TRAITEMENT DU CANCER

    Expires Wed Apr 09 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  16. WO 2022053708

    COMBINAISONS PHARMACEUTIQUES DESTINÉES À ÊTRE UTILISÉES POUR LE TRAITEMENT D'UN ADÉNOCARCINOME GASTRIQUE

    Expires Wed Mar 12 2042 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  17. AR 119500

    DERIVADOS DE 1,2,4-OXADIAZOL-5-ONA PARA EL TRATAMIENTO DEL CÁNCER

    Expires Tue Dec 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  18. AU 2019328599

    Compounds and methods for treating fungal infections

    Expires Wed Apr 17 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  19. WO 2021048135

    COMBINAISONS PHARMACEUTIQUES COMPRENANT UN FURAZANOBENZIMIDAZOLE ET UN AGONISTE DE CD40 POUR UNE UTILISATION DANS LE TRAITEMENT DE MALADIES NÉOPLASIQUES

    Expires Wed Mar 13 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  20. AU 2019294474

    Pyridine derivatives substituted by heterocyclic ring and amino group

    Expires Wed Feb 06 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  21. CA 3147876

    DERIVES DE LA 1,2,4-OXADIAZOL-5-ONE POUR LE TRAITEMENT DU CANCER

    Expires Wed Jan 30 2041 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  22. AR 113437

    INHIBIDORES MITOCONDRIALES PARA EL TRATAMIENTO DE TRASTORNOS DE PROLIFERACIÓN

    Expires Tue May 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  23. WO 2020058405

    ASSOCIATIONS PHARMACEUTIQUES DESTINÉES À ÊTRE UTILISÉES DANS LE TRAITEMENT DU CANCER

    Expires Wed Mar 21 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  24. CA 3103888

    PROCEDE DE PURIFICATION DE SULFATE D'ISAVUCONAZONIUM

    Expires Wed Feb 01 2040 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted
  25. WO 2019115709

    INHIBITEURS MITOCHONDRIALES POUR LE TRAITEMENT DE TROUBLES PROLIFÉRATIFS

    Expires Wed Jun 15 2039 00:00:00 GMT+0000 (Coordinated Universal Time)

    granted

Frequently asked questions

How many patents does Basilea Pharmaceutica have?

25 published patents match the current filter (all indexed). The full portfolio is indexed from USPTO PatentsView (A61K/A61P).

When do Basilea Pharmaceutica patents expire?

0 patents in the full portfolio expire within 24 months. Use the expiring filters above or open individual patent pages for grant and expiration dates.